Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
CC transcript
|
|
PALISADE BIO, INC. (CUR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/05/2023 |
4
| Finley John David (CEO, CFO, Director) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Paid exercise price by delivering 397 shares
@ $0.5501, valued at
$218.4
Exercised 1,309 options to buy
@ $0 |
|
| 09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/14/2023 |
4
| Finley John David (CEO, CFO, Director) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Paid exercise price by delivering 1,040 shares
@ $0.7, valued at
$728
Exercised 3,475 options to buy
@ $0 |
|
| 07/06/2023 |
4
| Finley John David (CEO, CFO, Director) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Paid exercise price by delivering 389 shares
@ $1.764, valued at
$686.2
Exercised 1,309 options to buy
@ $0 |
|
| 04/05/2023 |
4
| McRae Robert Curtis (COO) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Paid exercise price by delivering 270 shares
@ $2, valued at
$540
Exercised 655 options to buy
@ $0 |
|
| 04/05/2023 |
4
| Finley John David (CEO, CFO, Director) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Paid exercise price by delivering 435 shares
@ $2.01, valued at
$874.4
Exercised 1,309 options to buy
@ $0 |
|
| 02/08/2023 |
4
| Finley John David (CEO, CFO, Director) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Granted 41,700 options to buy
@ $0
Granted 32,500 options to buy
@ $0
Granted 57,200 options to buy
@ $2.4, valued at
$137.3k
|
|
| 01/06/2023 |
4
| Finley John David (CEO) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Granted 5,236 options to buy
@ $0 |
|
| 09/02/2022 |
4
| Finley John David (CFO) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Bought 19,481 shares
@ $0.1437, valued at
$2.8k
|
|
| 08/25/2022 |
4
| Finley John David (CFO) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Bought 7,350 shares
@ $0.16, valued at
$1.2k
|
|
| 08/18/2022 |
4
| Hallam Thomas (CEO) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Bought 40,000 shares
@ $0.25, valued at
$10k
Bought 40,000 options to buy
@ $0.25, valued at
$10k
|
|
| 08/18/2022 |
4
| Finley John David (CFO) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Bought 100,000 shares
@ $0.25, valued at
$25k
Bought 100,000 options to buy
@ $0.25, valued at
$25k
|
|
| 05/02/2022 |
4
| Finley John David (CFO) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Acquired 12,545 shares
@ $0 |
|
| 03/31/2022 |
4
| Dawson Michael John (Chief Medical Officer) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Bought 15,000 shares
@ $1.1395, valued at
$17.1k
|
|
| 03/29/2022 |
4
| Hallam Thomas (CEO) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Bought 10,000 shares
@ $1.18, valued at
$11.8k
|
|
| 03/25/2022 |
4
| Finley John David (CFO) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Bought 7,500 shares
@ $1.0899, valued at
$8.2k
|
|
| 02/22/2022 |
4
| Hallam Thomas (CEO) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Granted 156,600 options to buy
@ $0.95, valued at
$148.8k
|
|
| 02/22/2022 |
4
| Finley John David (CFO) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Granted 64,800 options to buy
@ $0.95, valued at
$61.6k
|
|
| 02/22/2022 |
4
| Dawson Michael John (Chief Medical Officer) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Granted 32,400 options to buy
@ $0.95, valued at
$30.8k
|
|
| 02/10/2022 |
4
| Dawson Michael John (Chief Medical Officer) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Granted 39,294 options to buy
@ $2.32, valued at
$91.2k
|
|
| 02/10/2022 |
4
| Finley John David (CFO) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Granted 178,091 options to buy
@ $2.32, valued at
$413.2k
|
|
| 02/10/2022 |
4
| Hallam Thomas (CEO) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Granted 267,868 options to buy
@ $2.32, valued at
$621.5k
|
|
| 02/10/2022 |
4
| Trenschel Robert J. (Director) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Granted 48,340 options to buy
@ $2.32, valued at
$112.1k
|
|
| 02/10/2022 |
4
| Williams Donald Allen (Director) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Granted 48,340 options to buy
@ $2.32, valued at
$112.1k
|
|
| 02/10/2022 |
4
| Neal James R (Director) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Granted 48,340 options to buy
@ $2.32, valued at
$112.1k
|
|
| 02/10/2022 |
4
| Diaz Stephanie (Director) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Granted 48,340 options to buy
@ $2.32, valued at
$112.1k
|
|
| 02/10/2022 |
4
| Wei Binxian (Director) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Granted 48,340 options to buy
@ $2.32, valued at
$112.1k
|
|
| 02/10/2022 |
4
| Csimma Cristina (Director) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Granted 48,340 options to buy
@ $2.32, valued at
$112.1k
|
|
| 02/10/2022 |
4
| GRAY MARY ANN (Director) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Granted 48,340 options to buy
@ $2.32, valued at
$112.1k
|
|
| 09/22/2021 |
4
| Finley John David (CFO) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Bought 2,000 shares
@ $2.44, valued at
$4.9k
|
|
| 09/22/2021 |
4
| Hallam Thomas (CEO) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Bought 6,000 shares
@ $2.49, valued at
$14.9k
|
|
| 09/13/2021 |
4
| Trenschel Robert J. (Director) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Bought 1,750 shares
@ $2.75, valued at
$4.8k
Bought 2,707 shares
@ $2.78, valued at
$7.5k
Bought 5,000 shares
@ $2.75, valued at
$13.8k
Bought 3,400 shares
@ $2.89, valued at
$9.8k
Bought 2,142 shares
@ $2.98, valued at
$6.4k
|
|
| 08/30/2021 |
4
| Finley John David (CFO) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Bought 1,600 shares
@ $2.63, valued at
$4.2k
Bought 8,400 shares
@ $2.65, valued at
$22.3k
|
|
|
|
|